ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

GSK GSK plc

41.91
0.30 (0.72%)
Pre Market
Last Updated: 11:28:01
Delayed by 15 minutes
Name Symbol Market Type
GSK plc NYSE:GSK NYSE Depository Receipt
  Price Change % Change Price High Price Low Price Open Price Traded Last Trade
  0.30 0.72% 41.91 7,291 11:28:01

GlaxoSmithKline plc 4Q 2014 -- Forecast

30/01/2015 6:10pm

Dow Jones News


GSK (NYSE:GSK)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more GSK Charts.

FRANKFURT--The following is a summary of analysts' forecasts for GlaxoSmithKline plc (GSK) fourth-quarter results, based on a poll of 12 analysts conducted by Dow Jones Newswires (figures in million pound, EPS, dividend and target price in pence, according to IFRS). Earnings figures are scheduled to be released February 4.

=== 
                            Core      Core        Core 
                Turnover  operat.   Pretax  Net attrib. Core 
4th Quarter        total   profit   profit      profit   EPS 
AVERAGE            6,151    1,833    1,660       1,244    26 
Prev. Year         6,700    2,020    1,876       1,393    29 
+/- in %            -8.2     -9.3      -12         -11   -10 
 
MEDIAN             6,182    1,808    1,652       1,232    26 
Maximum            6,273    2,054    1,757       1,320    29 
Minimum            5,966    1,737    1,584       1,198    25 
Amount                12       12        9           8    12 
 
Baader-Helvea      6,101    1,800    1,652          --    26 
Barclays           6,223    1,788    1,636       1,229    26 
Berenberg          6,074    1,772    1,625       1,209    25 
Bernstein          6,273    1,915    1,757       1,309    27 
Cowen and Company  6,185    1,819    1,668       1,253    26 
Deutsche Bank      6,235    1,767    1,629       1,200    25 
Exane BNP Paribas  5,966    1,808       --          --    26 
J.P. Morgan        6,045    1,737    1,584       1,198    25 
Jefferies          6,183    1,897    1,719       1,320    28 
Kepler Cheuvreux   6,151    2,054       --          --    29 
Morgan Stanley     6,180    1,830    1,671       1,234    26 
UBS                6,196    1,808       --          --    25 
 
 
            Target price  Rating                  DPS 2014 
 
AVERAGE            1.480  positive 2      AVERAGE       80 
Prev. Quarter      1.486  neutral  6      Prev. Year    78 
+/- in %            -0.4  negative 3      +/- in %    +2.6 
 
MEDIAN             1.530                  MEDIAN        80 
Maximum            1.700                  Maximum       80 
Minimum            1.250                  Minimum       80 
Amount                 9                  Amount         6 
 
Baader-Helvea      1.530  Hold                          -- 
Barclays           1.700  Overweight                    80 
Berenberg          1.620  Hold                          80 
Cowen                 --  Marketperform                 -- 
Deutsche Bank      1.300  Hold                          80 
Exane BNP Paribas  1.330  Underperform                  80 
J.P. Morgan           --  Underweight                   -- 
Jefferies          1.350  Hold                          -- 
Kepler Cheuvreux   1.540  Hold                          -- 
Morgan Stanley     1.700  Overweight                    80 
UBS                1.250  Sell                          80 
=== 

Year-earlier figures are as restated by the company.

DJG/voi 

Subscribe to WSJ: http://online.wsj.com?mod=djnwires


1 Year GSK Chart

1 Year GSK Chart

1 Month GSK Chart

1 Month GSK Chart

Your Recent History

Delayed Upgrade Clock